HERZLIYA, Israel and CALGARY, Alberta, Nov. 24, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication of a research article titled...
Hence then, the article about innocan pharma announces promising translational evidence from a pain relief study of repeated lpt cbd administration in goats was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats )
Also on site :
- Elon Musk’s judge has ‘significant misgivings’ about $1.5 million Twitter settlement—but approves it anyway
- Quote of the Day: Pope Francis on Having an Open Heart, Staying Confident and Never Giving Up
- Photos: Israeli attacks kill nine people, including two children, in Gaza